OBJECTIVE: Dynamic cytokine profiles from endogenously activated T cells in transit from lymph node to the infected sites via the blood compartment after recent exposure to Mycobacterium tuberculosis may differentiate disease progressors from non-disease progressors in a BCG-vaccinated population. METHODS: Household contacts (N = 107) from families with (six families) or without (14 families) secondary cases were assessed for Types 1 and 2 cytokines serially in plasma of whole blood cultures without exogenous stimulation. "ARMS" PCR was carried out for detection of single nucleotide polymorphism T/A in IFN-γ +874. RESULTS: In the absence of IFN-γ expansion, raised IL-4 at 6 months was associated with disease progression in TB-susceptible families. Resistant families on the other hand showed overrepresentation of IFN-γ +874 A allele and expansion of IFN-γ secreting cells at 6 months followed by contraction at 12 months. CONCLUSION: Six months may be an important checkpoint for biomarker assessment in high-risk individuals post-exposure.
OBJECTIVE: Dynamic cytokine profiles from endogenously activated T cells in transit from lymph node to the infected sites via the blood compartment after recent exposure to Mycobacterium tuberculosis may differentiate disease progressors from non-disease progressors in a BCG-vaccinated population. METHODS: Household contacts (N = 107) from families with (six families) or without (14 families) secondary cases were assessed for Types 1 and 2 cytokines serially in plasma of whole blood cultures without exogenous stimulation. "ARMS" PCR was carried out for detection of single nucleotide polymorphism T/A in IFN-γ +874. RESULTS: In the absence of IFN-γ expansion, raised IL-4 at 6 months was associated with disease progression in TB-susceptible families. Resistant families on the other hand showed overrepresentation of IFN-γ +874 A allele and expansion of IFN-γ secreting cells at 6 months followed by contraction at 12 months. CONCLUSION: Six months may be an important checkpoint for biomarker assessment in high-risk individuals post-exposure.
Authors: Alison M Elliott; Wendy S Hodsdon; Jacqueline Kyosiimire; Maria A Quigley; Jessica S Nakiyingi; Proscovia B Namujju; Christine Watera; Neil French; Charles F Gilks; Hazel M Dockrell; James A G Whitworth Journal: Trans R Soc Trop Med Hyg Date: 2004-11 Impact factor: 2.184
Authors: E Jouanguy; F Altare; S Lamhamedi; P Revy; J F Emile; M Newport; M Levin; S Blanche; E Seboun; A Fischer; J L Casanova Journal: N Engl J Med Date: 1996-12-26 Impact factor: 91.245
Authors: Aysefa Doganci; Tatjana Eigenbrod; Norbert Krug; George T De Sanctis; Michael Hausding; Veit J Erpenbeck; El-Bdaoui Haddad; Hans A Lehr; Edgar Schmitt; Tobias Bopp; Karl-J Kallen; Udo Herz; Steffen Schmitt; Cornelia Luft; Olaf Hecht; Jens M Hohlfeld; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Stefan Rose-John; Harald Renz; Markus F Neurath; Peter R Galle; Susetta Finotto Journal: J Clin Invest Date: 2005-02 Impact factor: 14.808
Authors: E Jouanguy; S Dupuis; A Pallier; R Döffinger; M C Fondanèche; C Fieschi; S Lamhamedi-Cherradi; F Altare; J F Emile; P Lutz; P Bordigoni; H Cokugras; N Akcakaya; J Landman-Parker; J Donnadieu; Y Camcioglu; J L Casanova Journal: J Clin Invest Date: 2000-05 Impact factor: 14.808
Authors: Johannes Nemeth; Heide-Maria Winkler; Lucas Boeck; Ayola A Adegnika; Ella Clement; Toung M Mve; Peter G Kremsner; Stefan Winkler Journal: Clin Immunol Date: 2010-10-15 Impact factor: 3.969
Authors: Abebech Demissie; Markos Abebe; Abraham Aseffa; Graham Rook; Helen Fletcher; Alimuddin Zumla; Karin Weldingh; Inger Brock; Peter Andersen; T Mark Doherty Journal: J Immunol Date: 2004-06-01 Impact factor: 5.422
Authors: Saeed Akhtar; Franklin White; Rumina Hasan; Shafquat Rozi; Mohammad Younus; Faiza Ahmed; Sara Husain; Bilquis Sana Khan Journal: BMC Public Health Date: 2007-05-03 Impact factor: 3.295
Authors: Dolly Jackson-Sillah; Jacqueline M Cliff; Gloria Ivy Mensah; Emmanuel Dickson; Sandra Sowah; John K A Tetteh; Kwasi K Addo; Tom H M Ottenhoff; Graham Bothamley; Hazel M Dockrell Journal: PLoS One Date: 2013-06-27 Impact factor: 3.240
Authors: Yohhei Hamada; Philippe Glaziou; Charalambos Sismanidis; Haileyesus Getahun Journal: Bull World Health Organ Date: 2019-05-28 Impact factor: 9.408
Authors: Suraj P Parihar; Mumin Ozturk; Maxine A Höft; Julius E Chia; Reto Guler; Roanne Keeton; Ilana C van Rensburg; Andre G Loxton; Frank Brombacher Journal: Front Immunol Date: 2021-06-15 Impact factor: 7.561